제약, 지주회사
Location: South Korea, Seoul
Employees: 1001-5000
Investors 1
| Date | Name | Website |
| - | SBI Invest... | sbik.co.kr |
Mentions in press and media 8
| Date | Title | Description |
| 16.01.2026 | Final Entry Deadline in 2026 Asia-Pacific Stevie® Awards Extended to 30 January | Stevie-winners to be celebrated at a ceremony in Macau on 17 April FAIRFAX, Va. , Jan. 16, 2026 /PRNewswire/ -- The Stevie® Awards, organizer of the world's premier business awards programs, announced that they have revised the schedule for... |
| 18.11.2025 | Call for Entries Issued for 13th Annual Asia-Pacific Stevie® Awards | New Awards Categories for AI Innovation and Podcasts FAIRFAX, Va., Nov. 18, 2025 /PRNewswire/ -- The Stevie® Awards are now accepting nominations for the 2026 (13th annual) Asia-Pacific Stevie® Awards, the only business awards program to re... |
| 13.03.2025 | WuXi Biologics and WuXi XDC: Pioneering the Future of Biologics and ADCs | In the fast-paced world of biotechnology, two names are making waves: WuXi Biologics and WuXi XDC. Both companies are at the forefront of innovation, pushing the boundaries of what's possible in drug development and manufacturing. Their rec... |
| 11.03.2025 | High-Trend International Group Announces the Completion of a $4,452,999 Private Placement of Ordinary Shares to Its Co-Founder, Mr. Dong Zhang At a Price of $2.62 Per Share with a Three-year Lock-up | SINGAPORE, March 11, 2025 /PRNewswire/ -- High-Trend International Group (NASDAQ: HTCO) (the "Company"), an international shipping company, today announced that Mr. Dong Zhang, a co-founder of the Company, has reaffirmed his commi... |
| 11.03.2025 | WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs | SHANGHAI and SEOUL, South Korea , March 11, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organiza... |
| 06.09.2022 | Dong-A ST and Beactica Therapeutics mutually agree to conclude oncology collaboration | Dong-A ST and Beactica Therapeutics mutually agree to conclude oncology collaboration Tue, Sep 06, 2022 08:00 CET Report this content Dong-A ST Co., Ltd. (170900: Korea SE), a Korean pharmaceutical company, and Beactica Therapeutics AB, a S... |
| 30.04.2012 | What does Warner Chilcott have to offer a potential buyer? | The company, which has U.S. offices in Rockaway, New Jersey, has several hormonal contraceptive and hormone therapy products in various stages of development. It is also developing a new generation of osteoporosis drugs in postmenopausal wo... |
| - | What does Warner Chilcott have to offer a potential buyer? | As Warner Chilcott (NASDAQ: WCRX) acknowledged in an announcement Monday that it is considering strategic options, it’s good time to look at what the company has to offer a prospective buyer in what has become a busy M&A landscape. The ... |